I.v. Fat Emulsion
Generic Name: i.v. fat emulsion
Brand Names:
Intralipid
I.V. fat emulsion is a sterile, non-pyrogenic lipid emulsion containing soybean oil with egg phospholipids and glycerin, used as a source of calories and essential fatty acids for parenteral nutrition.
Overview
I.V. fat emulsion is a sterile, non-pyrogenic lipid emulsion containing soybean oil with egg phospholipids and glycerin, used as a source of calories and essential fatty acids for parenteral nutrition.
Uses
Source of calories and essential fatty acids for adults and pediatric patients requiring parenteral nutrition. Also used for essential fatty acid deficiency (EFAD) prevention.
Dosage
Intravenous infusion into peripheral or central vein. Dosing depends on age and clinical status: 0.5-3 g/kg/day for neonates, 1-2.5 g/kg/day for older patients.
Side Effects
Most common in adults: nausea, vomiting, pyrexia. In pediatric patients: anemia, vomiting, increased gamma-glutamyltransferase, cholestasis.
Interactions
Vitamin K antagonists (warfarin): anticoagulant activity may be counteracted. Increase monitoring of coagulation parameters.
Warnings
Risk of clinical decompensation with rapid infusion in neonates/infants. Risks include parenteral nutrition-associated liver disease, hypersensitivity reactions, infections, fat overload syndrome, hypertriglyceridemia, aluminum toxicity. Contraindicated in known hypersensitivity to egg, soybean, or peanut, and severe hypertriglyceridemia.
Pregnancy
Not expected to cause birth defects at recommended doses. Severe malnutrition in pregnancy warrants parenteral nutrition consideration.
Storage
Store below 25 degrees C (77 degrees F). Do not freeze. Single-dose containers: use immediately or refrigerate at 2-8 degrees C for max 24 hours.
Frequently Asked Questions
What is I.v. Fat Emulsion used for?▼
Source of calories and essential fatty acids for adults and pediatric patients requiring parenteral nutrition. Also used for essential fatty acid deficiency (EFAD) prevention.
What are the side effects of I.v. Fat Emulsion?▼
Most common in adults: nausea, vomiting, pyrexia. In pediatric patients: anemia, vomiting, increased gamma-glutamyltransferase, cholestasis.
Can I take I.v. Fat Emulsion during pregnancy?▼
Not expected to cause birth defects at recommended doses. Severe malnutrition in pregnancy warrants parenteral nutrition consideration.
What are the important warnings for I.v. Fat Emulsion?▼
Risk of clinical decompensation with rapid infusion in neonates/infants. Risks include parenteral nutrition-associated liver disease, hypersensitivity reactions, infections, fat overload syndrome, hypertriglyceridemia, aluminum toxicity. Contraindicated in known hypersensitivity to egg, soybean, or peanut, and severe hypertriglyceridemia.
Related Medications
Ibuprofen And Pseudoephedrine Hydrochloride
ibuprofen and pseudoephedrine hydrochloride
Nonsteroidal Anti-inflammatory Drug [EPC]
PURPOSES Pain reliever/fever reducer Nasal decongestant
Amivantamab And Hyaluronidase-lpuj (human Recombinant)
amivantamab and hyaluronidase-lpuj (human recombinant)
Endoglycosidase [EPC]
11 DESCRIPTION RYBREVANT FASPRO is a fixed-combination drug product containing amivantamab and hyaluronidase (human recombinant). Amivantamab is a low-fucose human immunoglobulin G1-based bispecific antibody directed against the EGF and MET receptors, produced by mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology that has a molecular weight of approximately 148 kDa.
Orange Citrus Sinensis
orange citrus sinensis
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ORANGE (.1 g/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.